Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting

BACKGROUND: Acute myeloid leukemia (AML) is the most common acute leukemia in adults and has an unacceptably low cure rate. In recent years, a number of new treatment strategies and compounds were developed for the treatment of AML. There were several randomized controlled clinical trials with the o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Katharina M., Harrison, Kathryn L., Williamson, Paula R., Huntly, Brian J. P., Ossenkoppele, Gert, Geissler, Jan, Bereczky, Tamàs, Hernández-Rivas, Jesús M., Chevrou-Séverac, Hélène, Goodbody, Rory, Schulze-Rath, Renate, Bullinger, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251906/
https://www.ncbi.nlm.nih.gov/pubmed/32460828
http://dx.doi.org/10.1186/s13063-020-04384-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251906/
https://www.ncbi.nlm.nih.gov/pubmed/32460828
http://dx.doi.org/10.1186/s13063-020-04384-1

Ejemplares similares